Results 41 to 50 of about 3,487 (207)

Patterns of white and gray structural abnormality associated with paediatric demyelinating disorders

NeuroImage: Clinical, 2022
The impact of multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein (MOG) - associated disorders (MOGAD) on brain structure in youth remains poorly understood.
Sonya Bells, Giulia Longoni, Tara Berenbaum, Cynthia B. de Medeiros, Sridar Narayanan, Brenda L. Banwell, Douglas L. Arnold, Donald J. Mabbott, E. Ann Yeh   +8 more
doaj   +1 more source

Table_6_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX

, 2022
BackgroundMyelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS.
Omri Zveik (12283328), Ariel Rechtman (12283325), Benjamin Uliel (12283331), Atira S. Bick (12283337), Livnat Brill (3425690), Adi Vaknin-Dembinsky (110061), Netta Levin (711894), Nitzan Haham (12283334)   +7 more
core   +1 more source

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review

Journal of Central Nervous System Disease, 2023
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an uncommon neurological disease affecting the central nervous system (CNS).
Omid Mirmosayyeb, Elham Moases Ghaffary, Mohammad S. Dehghan, Hamed Ghoshouni, Sara Bagherieh, Mahdi Barzegar, Vahid Shaygannejad   +6 more
doaj   +1 more source

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis

Frontiers in Immunology, 2023
BackgroundMyelin oligodendrocyte glycoprotein antibody-associated autoimmune disease (MOGAD) is a rare monophasic or relapsing inflammatory demyelinating disease of the central nervous system (CNS) and can mimic multiple sclerosis (MS).
Benjamin Vlad, Benjamin Vlad, Ina Reichen, Ina Reichen, Stephan Neidhart, Stephan Neidhart, Marc Hilty, Marc Hilty, Dimitra Lekaditi, Dimitra Lekaditi, Christine Heuer, Christine Heuer, Amanda Eisele, Amanda Eisele, Mario Ziegler, Mario Ziegler, Markus Reindl, Andreas Lutterotti, Andreas Lutterotti, Axel Regeniter, Ilijas Jelcic, Ilijas Jelcic   +21 more
doaj   +1 more source

The diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children

Exploration of Neuroprotective Therapy
Over the last two decades, immunoglobulin G (IgG) antibodies against myelin oligodendrocyte glycoprotein (MOG), previously thought to be a biomarker of multiple sclerosis (MS), have been shown to cause a distinct disease called MOG antibody-associated ...
Ünsal Yılmaz
doaj   +1 more source

The use of OCT in good visual acuity MOGAD and AQP4-NMOSD patients; with and without optic neuritis

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2021
Myelin oligodendrocyte-antibody-associated disease (MOGAD) often presents with severe optic neuritis (ON) but tends to recover better than in aquaporin-4 antibody neuromyelitis optica spectrum disorder (AQP4-NMOSD).
A Roca-Fernández, V Camera, G Loncarevic-Whitaker, S Messina, R Mariano, A Vincent, S Sharma, MI Leite, J Palace   +8 more
doaj   +1 more source

MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review

Frontiers in Neurology, 2022
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disorder (MOGAD) is a newly identified autoimmune demyelinating disorder that is often associated with acute disseminated encephalomyelitis and usually occurs postinfection or postvaccination.
Yuki Matsumoto, Ayane Ohyama, Takafumi Kubota, Kensuke Ikeda, Kimihiko Kaneko, Yoshiki Takai, Hitoshi Warita, Toshiyuki Takahashi, Tatsuro Misu, Masashi Aoki, Masashi Aoki   +10 more
doaj   +1 more source

Image_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF

, 2022
BackgroundMyelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS.
Omri Zveik (12283328), Ariel Rechtman (12283325), Benjamin Uliel (12283331), Atira S. Bick (12283337), Livnat Brill (3425690), Adi Vaknin-Dembinsky (110061), Netta Levin (711894), Nitzan Haham (12283334)   +7 more
core   +1 more source

Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study

Frontiers in Immunology, 2023
PurposeTo compare the optical coherence tomography (OCT)/OCT angiography (OCTA) measures in patients with neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD).MethodsTwenty-one MOG, 21 NMOSD, and
Yanlin Lang, William Robert Kwapong, Lingyao Kong, Ziyan Shi, Xiaofei Wang, Qin Du, Bo Wu, Hongyu Zhou   +7 more
doaj   +1 more source

Table_8_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX

, 2022
BackgroundMyelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS.
Omri Zveik (12283328), Ariel Rechtman (12283325), Benjamin Uliel (12283331), Atira S. Bick (12283337), Livnat Brill (3425690), Adi Vaknin-Dembinsky (110061), Netta Levin (711894), Nitzan Haham (12283334)   +7 more
core   +1 more source